Terkko Navigator / Lotta/ Feeds

Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer

The role of postoperative radiation therapy in stage I–III male breast cancer: A population-based study from the surveillance, epidemiology, and End Results database

The evolving clinical use of prostate cancer biomarkers

Optimizing anti-androgen treatment use among men with pathologic lymph-node positive prostate cancer treated with radical prostatectomy: the importance of postoperative PSA kinetics

No Effect on Tumorigenesis in MG63 Cells Induced by Co-Cultured Mesenchymal Stem Cells

A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma

Immune-Related lncRNAs with WGCNA Identified the Function of SNHG10 in HBV-Related Hepatocellular Carcinoma

Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer

Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia

Topoisomerase I poison-triggered immune gene activation is markedly reduced in human small-cell lung cancers by impairment of the cGAS/STING pathway

PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM

EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer

Correction to: Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma

Lactate dehydrogenase as promising marker for prognosis of brain metastasis

Erratum to “GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396]

MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma

Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study

Molecular pathology testing for non-small cell lung cancer: an observational study of elements currently present in request forms and result reports and the opinion of different stakeholders

HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC

Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK

Current State of Funded National Cancer Institute Grants That Include Economic Analyses

Cancer Health Economics Research: The Future Is Now

Fostering Transdisciplinary Collaborations in Cancer Health Economics Research

A History of Health Economics and Healthcare Delivery Research at the National Cancer Institute

How Data Security Concerns Can Hinder Natural Experiment Research: Background and Potential Solutions

New Data Resources, Linkages, and Infrastructure for Cancer Health Economics Research: Main Topics From a Panel Discussion

Communicating Research to Non-Researcher Audiences: A Panel Discussion From the National Cancer Institute's Future of Cancer Health Economics Research Conference

Health Economics Research in Primary Prevention of Cancer: Assessment, Current Challenges, and Future Directions

Cancer Survivorship and Supportive Care Economics Research: Current Challenges and Next Steps

Methods and Study Design for Cancer Health Economics Research: Summary of Discussions From a Breakout Session

Cancer-Related Care Costs and Employment Disruption: Recommendations to Reduce Patient Economic Burden as Part of Cancer Care Delivery

Research on the Economics of Cancer-Related Health Care: An Overview of the Review Literature

Introduction to the Supplement: Is Now the Time for the Future of Cancer Economics Research?

Health Economics Research in Cancer Treatment: Current Challenges and Future Directions

Enhancing Health Equity Through Cancer Health Economics Research

Health Economics Research in Cancer Screening: Research Opportunities, Challenges, and Future Directions

Respectful Maternity Care in South Asia: What Does the Evidence Say? Experiences of Care and Neglect, Associated Vulnerabilities and Social Complexities

Risk-adapted modulation through de-intensification of cancer treatments: An ESMO classification

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

Mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma

LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway

Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents

Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer

The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer

Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis

Meet the Editorial Board Member

Anti-cancer Research on Arnebiae radix-derived Naphthoquinone in Recent Five Years

Non-histone Methylation of SET7/9 and its Biological Functions

Targeting Notch Pathway in Cancer Diagnostics and Therapeutics: An Emerging Approach

Transdermal Drug Delivery: A Step towards Treatment of Cancer